Gritstone Bio Inc (NQ: GRTS )

0.0509 -0.0112 (-18.04%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 11, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 63,232,611
Open 0.0645
Bid (Size) 0.0500 (687)
Ask (Size) 0.0511 (54)
Prev. Close 0.0621
Today's Range 0.0492 - 0.0645
52wk Range 0.0492 - 3.170
Shares Outstanding 93,075,427
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Why Aehr Test Systems Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket
Via Benzinga
S&P Moves Lower; Domino's Pizza Posts Mixed Q3 Results
Via Benzinga
Topics Stocks
Exposures US Equities

Performance

YTD
-97.67%
-97.67%
1 Month
-89.65%
-89.65%
3 Month
-92.17%
-92.17%
6 Month
-93.95%
-93.95%
1 Year
-97.91%
-97.91%

More News

Read More
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Crude Oil Surges 3%; Delta Air Lines Posts Downbeat Earnings
Via Benzinga
Exposures Fossil Fuels
Why Gritstone Bio (GRTS) Stock Is Down 64% Today
Via Benzinga
Key Takeaways From Gritstone Bio Analyst Ratings
Via Benzinga
Where Gritstone Bio Stands With Analysts
Via Benzinga
Dow Falls Over 100 Points; US Inflation Rate Slows To 2.4% In September
Via Benzinga
Topics Economy Stocks
Exposures Interest Rates US Equities
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Gritstone bio Takes Action to Preserve Value and Strengthen Capital Structure
From Gritstone bio, Inc.
Via Business Wire
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Penny Stock Gritstone Bio Hires Advisor To Evaluate Options, Analyst Downgrades Stock As Data 'Insufficient To Excite Many Investors'
Via Benzinga
Exposures Product Safety
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Gritstone bio Announces Interim Phase 2 Data for GRANITE Individualized Neoantigen Targeting Immunotherapy in Frontline Metastatic Microsatellite Stable Colorectal Cancer
From Gritstone bio
Via GlobeNewswire
GRTS Stock Earnings: Gritstone Bio Beats EPS, Misses Revenue for Q2 2024
Via InvestorPlace
Gritstone bio Reports Second Quarter 2024 Financial Results and Provides Corporate Updates
From Gritstone bio
Via GlobeNewswire
GRITSTONE ALERT: Bragar Eagel & Squire, P.C. is Investigating Gritstone bio, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
GRTS Investors Have Opportunity to Join Gritstone bio, Inc. Fraud Investigation with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
GRTS Deadline: Rosen Law Firm Urges Gritstone bio, Inc. (NASDAQ: GRTS) Stockholders with Large Losses to Contact the Firm for Information About Their Rights
From The Rosen Law Firm, P.A.
Via Business Wire
GRTS Investors Have Opportunity to Join Gritstone bio, Inc. Fraud Investigation with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Scotts, Gritstone, Fat Brands, and Charge and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Gritstone
From Faruqi & Faruqi LLP
Via GlobeNewswire
GRTS Investors Have the Opportunity to Lead Gritstone bio, Inc. Securities Fraud Lawsuit with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Scotts, Gritstone, Fat Brands, and Charge and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.